Can a smart glucose monitor help type 2 diabetes patients on insulin?
NCT ID NCT07603284
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a real-time continuous glucose monitor (CGM) can help 200 adults with type 2 diabetes who use insulin in Saudi Arabia. Participants wear a CGM device that tracks blood sugar levels continuously. The main goal is to see if it improves HbA1c, a measure of average blood sugar, over 12 weeks, with a follow-up at 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Real-time continuous glucose monitoring device
- What this could lead to
- If successful, this could show that continuous glucose monitoring helps people with type 2 diabetes on insulin achieve better blood sugar control, potentially reducing complications.
- What could go wrong
- This is a relatively small, single-country study (200 participants) focused on short-term outcomes (12-24 weeks). Results may not apply to all populations or prove long-term benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES ON INSULIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Fahad Medical City
Riyadh, Saudi Arabia